TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
2.100
+0.010 (0.48%)
At close: Sep 18, 2026, 4:00 PM EDT
2.062
-0.038 (-1.80%)
After-hours: Sep 18, 2026, 7:30 PM EDT
TuHURA Biosciences Market Cap
TuHURA Biosciences has a market cap or net worth of $133.83 million as of September 18, 2026. Its market cap has increased by 10.04% in one year.
Market Cap
133.83M
Enterprise Value
142.01M
1-Year Change
10.04%
Ranking
Category
Stock Price
$2.10
ChartMarket Cap Chart
Since October 18, 2024, TuHURA Biosciences's market cap has decreased from $264.60M to $133.83M, a decrease of -49.42%. That is a compound annual growth rate of -29.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 133.83M | 191.26% |
| Dec 31, 2025 | 45.95M | -73.43% |
| Dec 31, 2024 | 172.94M | -34.64% |
| Oct 18, 2024 | 264.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immunic | 141.22M |
| Neumora Therapeutics | 140.92M |
| Caribou Biosciences | 140.44M |
| Corbus Pharmaceuticals Holdings | 140.42M |
| Unicycive Therapeutics | 132.87M |
| LENZ Therapeutics | 129.77M |
| Biomea Fusion | 129.75M |
| Milestone Pharmaceuticals | 129.58M |